Surmodics reported $60.04M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Align Technology ALGN:US $ 2376.8M 103.96M
Anika Therapeutics ANIK:US $ 167.86M 2.53M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Baxter International BAX:US $ 7882M 291M
Bioscrip BIOS:US $ 805.71M 95.46M
Cryolife CRY:US $ 244.53M 3.16M
Edap Tms EDAP:US $ 66.56M 0.82M
Edwards Lifesciences EW:US $ 3263.1M 21.8M
Haemonetics HAE:US $ 756.03M 26.58M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Merit Medical Systems MMSI:US $ 492.63M 14.54M
Mesa Laboratories MLAB:US $ 128.13M 3.81M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Stryker SYK:US $ 8825M 100M
Surmodics SRDX:US $ 60.04M 4.65M
Trinity Biotech TRIB:US $ 58.27M 14.42M